New hires:

Real Chemistry, a 2024 MM+M Agency 100 honoree, hired former Seagen exec Sherry Pudloski as group president of client solutions and integrated communications.

Arvinas hired Andrew Saik as CFO and treasurer.

London-based biotech Compass Pathways appointed Lori Englebert as chief commercial officer.

Arialys Therapeutics named Peter Flynn, PhD as its CEO.

CND Life Sciences expanded its leadership team with four new executive hires.

Anthony Manson joined Healio as chief digital officer.

Caitlyn Miller, PhD, founded TwoStep Therapeutics and will serve as CEO. The company will also be led by chief business officer Michael Ostrach and drug development and scientific advisor Robert Coffman, PhD. 

Miller was assisted in founding the company by Nobel Laureate Carolyn Bertozzi, PhD, Jennifer Cochran, PhD, senior associate vice provost for research and professor of bioengineering at Stanford University and Ronald Levy, MD, professor of medicine and oncology at the school. 

Intellia Therapeutics announced the appointment of Edward Dulac as EVP, CFO and treasurer, effective July 22. He succeeds Glenn Goddard who will step down from his role on June 30.

Health and wellness marketing agency Parallel Path added Dan Shust as director of AI and experience innovation.

Element Biosciences hired Amirali Kia, PhD as VP of AI and Tina Tian, PhD as VP of portfolio management.

Oluwadamilola (Dammie) Brown, MD joined the Colorectal Cancer Alliance as SVP of mission delivery, while Tina Zeff joined as chief operating officer.

Don Stanziano, MHA joined Banner Health as SVP for marketing, brand and public relations. 

Former Moderna executive Tal Zaks assumed the position of CEO of Exsilio Therapeutics.

MBX Biosciences named Salomon Azoulay, MD as chief medical officer.

Clinical research company Avallano Michael A. Ibara, PharmD as chief strategy officer.

Cybrexa Therapeutics added John Maraganore, PhD as a strategic advisor to its executive leadership team.

Executive elevations:

Sanofi promoted Audrey Duval Derveloy to EVP and global head of corporate affairs, effective July 1. 

Edelmannamed Courtney Gray Haupt and Jen Hauser global co-chairs of its health sector, effective July 1. 

The Bloc, a 2024 MM+M Agency 100 honoree, promoted two executives, Dan Sountupe and Matt Silver. 

Board appointments:

AbbVie named Roxanne S. Austin as lead independent director of the board of directors.

Takeda announced new assignments for the members of its board of directors.

Cour Pharmaceuticals added former Horizon Therapeutics CEO Tim Walbert to its board of directors.

Kiora Pharmaceuticals appointed Roger Goldberg, MD to its scientific advisory board.

Shape Therapeutics named David Epstein and Todd Simpson to its board of directors.

Aurobac Therapeutics – created by Boehringer IngelheimbioMérieux and Evotec – announced the creation of its scientific advisory board.

Former Arialys Therapeutics CEO Jay Lichter, PhD was named chair of the company’s board of directors.


Altimmune’s CFO Richard Eisenstadt passed away unexpectedly.

Traws Pharma announced Steven M. Fruchtman resigned as president and chief scientific officer of oncology.


The Tang Prize Foundation jointly awarded the 2024 Tang Prize in Biopharmaceutical Science to Joel F. Habener, Svetlana Mojsov and Jens Juul Holst for discovering GLP-1 as an insulinotropic factor as well as developing anti-diabetic and anti-obesity drugs.

See last week’s edition of The Escalator.